Marc Tallo-Parra

Company: NoctuRNA Therapeutics

Job title: Deputy CSO and co-founder

Seminars:

First-In-Class Circular RNA Therapy for the Treatment of “Incurable” Diseases 11:30 am

Highlighting the diverse roles circRNA plays in cellular processes, including gene regulation and signalling Exploring how circRNA therapy may provide novel solutions to address the challenges associate with incurable diseases Presenting specific examples of how circRNA therapy can intervene in the progression of treating incurable diseasesRead more

day: Conference Day Two